about
The Myosin II Inhibitor, Blebbistatin, Ameliorates FeCl3-induced Arterial Thrombosis via the GSK3β-NF-κB Pathway.Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration.Endothelial Dysfunction and Hypertension.Platelet-mimetic strategies for modulating the wound environment and inflammatory responses.Impact of thrombosis on pulmonary endothelial injury and repair following sepsis.The role of the tissue factor and its inhibitor in the development of subclinical atherosclerosis in people living with HIV.Prognostic Value of the CHADS2 Score for Adverse Cardiovascular Events in Coronary Artery Disease Patients Without Atrial Fibrillation-A Multi-Center Observational Cohort Study.Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets.Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial.Pulmonary hypertension: Molecular aspects of current therapeutic intervention and future direction.Endothelial Dysfunction and Venous Thrombosis.Gastroenteritis in an adult female revealing hemolytic uremic syndrome: Case report.Endothelial Cells.Prevention of thrombotic disorders by antithrombotic diet and exercise: evidence by using global thrombosis tests.Single and multiple dose evaluation of a novel MetAP2 inhibitor: Results of a randomized, double-blind, placebo-controlled clinical trial.Endothelial Mechanotransduction, Redox Signaling and the Regulation of Vascular Inflammatory Pathways.Thromboelastometry-guided hemostatic therapy for hemorrhagic shock in the postoperative period of vascular surgery: a case report.Intermedin protects against sepsis by concurrently re-establishing the endothelial barrier and alleviating inflammatory responses.
P2860
Q33717776-C474B336-FCE7-4880-A5F7-A150E510FF54Q37713328-551AEF17-324B-4349-9F22-6D53F81EA869Q38776339-480A004B-9891-4E38-B0FD-AC809F5EA252Q38837048-06046311-A2EB-4824-9E68-A8F71F9458E6Q39107051-76024BA2-5512-43B2-A61E-F8F685ACE47FQ40105787-C0FC6C53-9E32-453B-A312-D851FADBCE8CQ41628472-522C4830-C009-461E-A676-27B5F70F84EBQ42290659-BE1AA566-C0E5-4395-BAAD-2216EAB3858CQ45205513-436D4EC1-7F1D-48F4-819B-16E6749AAE72Q47941425-FDA19777-288E-40B5-8C73-00D1F05A6D72Q48280013-FE66C202-7F46-4DB0-B535-0D69C6E71185Q49885435-CD0B2DD3-DC47-48CB-8031-E2E35414D4FEQ50864381-BE56BE1B-F6C8-4207-804D-7E53F6FA6AAFQ52571175-8B36BEC2-2BA0-4485-940D-A049320CFF2BQ52632089-E051BB12-5648-438E-A70C-063116C05B4DQ55334826-7D5F160B-AA9A-4185-A362-D5486800E79BQ55427325-F7448403-404F-4800-956F-CA8F9EDBFD90Q55509951-FB9DCC96-9F6A-4247-ABA9-80FE975D1A93
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Endothelial cell control of thrombosis
@ast
Endothelial cell control of thrombosis
@en
Endothelial cell control of thrombosis
@nl
type
label
Endothelial cell control of thrombosis
@ast
Endothelial cell control of thrombosis
@en
Endothelial cell control of thrombosis
@nl
prefLabel
Endothelial cell control of thrombosis
@ast
Endothelial cell control of thrombosis
@en
Endothelial cell control of thrombosis
@nl
P2860
P921
P1476
Endothelial cell control of thrombosis
@en
P2093
Jonathan W Yau
Subodh Verma
P2860
P2888
P356
10.1186/S12872-015-0124-Z
P407
P50
P5008
P577
2015-10-19T00:00:00Z
P5875
P6179
1052151780